ETERNA THERAPEUTICS AND FACTOR BIOSCIENCE ANNOUNCE EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT TO ACCELERATE CELL THERAPY DEVELOPMENT FOR ONCOLOGY, AUTOIMMUNE, AND RARE DISEASES

Reuters · 10/17 12:00

Please log in to view news